SIBO in pediatric population: literature review on pathogenesis, symptoms, diagnosis and treatment
DOI:
https://doi.org/10.12775/QS.2024.15.52152Keywords
„SIBO, Small Intestinal Bacterial Overgrowth, SIBO in pediatric population, gastrointestinal symptoms, „SIBO diagnosisAbstract
Introduction:
SIBO is a condition characterized by bacterial overgrowth in the small intestine which is caused by various factors. The excessively proliferated bacteria can lead to digestive disturbances- manifesting as gastrointestinal symptoms and malabsorption. In pediatric patients, small intestinal bacterial overgrowth can also result in growth retardation. Due to many challenges related to the diagnosis and treatment of children- this condition should be well known by pediatric healthcare providers.
Aim of the study:
This study aims to summarizes the recent knowledge about the pathogenesis, symptoms, diagnosis and the treatment of small intestine bacterial overgrowth in pediatric population, providing an overview for healthcare professionals.
Material and methods:
The literature available in the PubMed database was reviewed using the following keywords: „SIBO”, „Small Intestinal Bacterial Overgrowth”, ,, „SIBO in pediatric population”, „Endoscopy in children”, „SIBO treatment”
Conclusion:
Small intestinal bacterial overgrowth is a complex disorder that can have a significant influence on the quality of life of pediatric patients. The variety of symptoms of this syndrome can lead to confusing clinical findings. The diagnostic pathway consists of a clinical evaluation and specific tests, to verify the presence of bacterial overgrowth. Effective treatment involves modifying the intestinal microbiota - mostly through antibiotic therapy - and supplementing nutritional deficiencies. Probiotics and dietary modifications, such as low-FODMAP diets, are often used as adjunctive therapies.
References
U. C. Ghoshal, R. Shukla, and U. Ghoshal, “Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy,” Gut Liver, vol. 11, no. 2, pp. 196–208, Mar. 2017, https://doi.org/10.5009/gnl16126
A. Gasbarrini et al., “Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.,” Aliment Pharmacol Ther, vol. 29 Suppl 1, pp. 1–49, Mar. 2009, https://doi.org/10.1111/j.1365-2036.2009.03951.x
E. Scarpellini et al., “Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.,” J Pediatr, vol. 155, no. 3, pp. 416–20, Sep. 2009, https://doi.org/10.1016/j.jpeds.2009.03.033
E. M. M. Quigley and B. Flourie, “Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.,” Neurogastroenterology and motility, vol. 19, no. 3, pp. 166–72, Mar. 2007, https://doi.org/10.1111/j.1365-2982.2006.00879.x
W.-K. Lo and W. W. Chan, “Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.,” Clin Gastroenterol Hepatol, vol. 11, no. 5, pp. 483–90, May 2013, https://doi.org/10.1016/j.cgh.2012.12.011
D. Bushyhead and E. M. M. Quigley, “Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management.,” Gastroenterology, vol. 163, no. 3, pp. 593–607, Sep. 2022, https://doi.org/10.1053/j.gastro.2022.04.002
R. Khoshini, S.-C. Dai, S. Lezcano, and M. Pimentel, “A systematic review of diagnostic tests for small intestinal bacterial overgrowth.,” Dig Dis Sci, vol. 53, no. 6, pp. 1443–54, Jun. 2008, https://doi.org/10.1007/s10620-007-0065-1
N. Sroka, A. Rydzewska-Rosołowska, K. Kakareko, M. Rosołowski, I. Głowińska, and T. Hryszko, “Show Me What You Have Inside-The Complex Interplay between SIBO and Multiple Medical Conditions-A Systematic Review.,” Nutrients, vol. 15, no. 1, Dec. 2022, https://doi.org/10.3390/nu15010090
D. Avelar Rodriguez, P. M. Ryan, E. M. Toro Monjaraz, J. A. Ramirez Mayans, and E. M. Quigley, “Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.,” Front Pediatr, vol. 7, p. 363, 2019, https://doi.org/10.3389/fped.2019.00363
U. C. Ghoshal and U. Ghoshal, “Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders.,” Gastroenterol Clin North Am, vol. 46, no. 1, pp. 103–120, Mar. 2017, https://doi.org/10.1016/j.gtc.2016.09.008
V. Chedid et al., “Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.,” Glob Adv Health Med, vol. 3, no. 3, pp. 16–24, May 2014, https://doi.org/10.7453/gahmj.2014.019
E. C. Lauritano et al., “Small intestinal bacterial overgrowth recurrence after antibiotic therapy.,” Am J Gastroenterol, vol. 103, no. 8, pp. 2031–5, Aug. 2008, https://doi.org/10.1111/j.1572-0241.2008.02030.x
M. Pimentel, E. J. Chow, and H. C. Lin, “Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study.,” Am J Gastroenterol, vol. 98, no. 2, pp. 412–9, Feb. 2003, https://doi.org/10.1111/j.1572-0241.2003.07234.x
A. Rezaie et al., “Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.,” Am J Gastroenterol, vol. 112, no. 5, pp. 775–784, May 2017, https://doi.org/10.1038/ajg.2017.46
A. Adike and J. K. DiBaise, “Small Intestinal Bacterial Overgrowth: Nutritional Implications, Diagnosis, and Management.,” Gastroenterol Clin North Am, vol. 47, no. 1, pp. 193–208, Mar. 2018, https://doi.org/10.1016/j.gtc.2017.09.008
E. Grace, C. Shaw, K. Whelan, and H. J. N. Andreyev, “Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment.,” Aliment Pharmacol Ther, vol. 38, no. 7, pp. 674–88, Oct. 2013, https://doi.org/10.1111/apt.12456
P. R. Gibson and S. J. Shepherd, “Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach.,” J Gastroenterol Hepatol, vol. 25, no. 2, pp. 252–8, Feb. 2010, https://doi.org/10.1111/j.1440-1746.2009.06149.x
S. Ehrlich, A. G. Mark, F. Rinawi, R. Shamir, and A. Assa, “Micronutrient Deficiencies in Children With Inflammatory Bowel Diseases.,” Nutr Clin Pract, vol. 35, no. 2, pp. 315–322, Apr. 2020, https://doi.org/10.1002/ncp.10373
A. Sieczkowska, P. Landowski, B. Kamińska, and C. Lifschitz, “Small Bowel Bacterial Overgrowth in Children.,” J Pediatr Gastroenterol Nutr, vol. 62, no. 2, pp. 196–207, Feb. 2016, https://doi.org/10.1097/MPG.0000000000000920
H. M. Serin and E. A. Arslan, “Neurological symptoms of vitamin B12 deficiency: analysis of pediatric patients.,” Acta Clin Croat, vol. 58, no. 2, pp. 295–302, Jun. 2019, https://doi.org/10.20471/acc.2019.58.02.13
Q.-Q. Xie et al., “Glucose substrate in the hydrogen breath test for gut microbiota determination: A recommended noninvasive test.,” World J Clin Cases, vol. 10, no. 26, pp. 9536–9538, Sep. 2022, https://doi.org/10.12998/wjcc.v10.i26.9536
A. Gasbarrini et al., “Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.,” Aliment Pharmacol Ther, vol. 29 Suppl 1, pp. 1–49, Mar. 2009, https://doi.org/10.1111/j.1365-2036.2009.03951.x
A. M. Madrid, G. Landskron, G. Klapp, A. Reyes, C. Pizarro, and C. Defilippi, “Lactulose hydrogen breath test and functional symptoms in pediatric patients.,” Dig Dis Sci, vol. 57, no. 5, pp. 1330–5, May 2012, https://doi.org/10.1007/s10620-012-2032-8
R. J. Saad and W. D. Chey, “Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy.,” Clin Gastroenterol Hepatol, vol. 12, no. 12, pp. 1964–72; quiz e119-20, Dec. 2014, https://doi.org/10.1016/j.cgh.2013.09.055
J. Bures et al., “Small intestinal bacterial overgrowth syndrome.,” World J Gastroenterol, vol. 16, no. 24, pp. 2978–90, Jun. 2010, https://doi.org/10.3748/wjg.v16.i24.2978
R. Wyllie and M. H. Kay, “Gastrointestinal endoscopy in infants and children.,” Pediatr Rev, vol. 14, no. 9, pp. 352–9; quiz 360, Sep. 1993, https://doi.org/10.1542/pir.14-9-352
S. V Rana and S. B. Bhardwaj, “Small intestinal bacterial overgrowth.,” Scand J Gastroenterol, vol. 43, no. 9, pp. 1030–7, 2008, https://doi.org/10.1080/00365520801947074
A. H. Sachdev and M. Pimentel, “Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.,” Ther Adv Chronic Dis, vol. 4, no. 5, pp. 223–31, Sep. 2013, https://doi.org/10.1177/2040622313496126
Y. K. Cho, J. Lee, and C. N. Paik, “Prevalence, risk factors, and treatment of small intestinal bacterial overgrowth in children.,” Clin Exp Pediatr, vol. 66, no. 9, pp. 377–383, Sep. 2023, https://doi.org/10.3345/cep.2022.00969
B. Skrzydło-Radomańska and B. Cukrowska, “How to Recognize and Treat Small Intestinal Bacterial Overgrowth?,” J Clin Med, vol. 11, no. 20, Oct. 2022, https://doi.org/10.3390/jcm11206017
P. Varjú et al., “Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.,” PLoS One, vol. 12, no. 8, p. e0182942, 2017, https://doi.org/10.1371/journal.pone.0182942
K. Whelan, L. D. Martin, H. M. Staudacher, and M. C. E. Lomer, “The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice.,” J Hum Nutr Diet, vol. 31, no. 2, pp. 239–255, Apr. 2018, https://doi.org/10.1111/jhn.12530
S. L. Peters, C. K. Yao, H. Philpott, G. W. Yelland, J. G. Muir, and P. R. Gibson, “Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome.,” Aliment Pharmacol Ther, vol. 44, no. 5, pp. 447–59, Sep. 2016, https://doi.org/10.1111/apt.13706
D. Campaniello et al., “How Diet and Physical Activity Modulate Gut Microbiota: Evidence, and Perspectives.,” Nutrients, vol. 14, no. 12, Jun. 2022, https://doi.org/10.3390/nu14122456
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Martyna Opatowska, Julita Gmitrzuk, Zuzanna Malinka, Katarzyna Wiśniewska, Anna Jachymek, Joanna Jakubiec, Tomasz Kucharski, Marta Piotrowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 235
Number of citations: 0
